Join our webinar where we will highlight key NextSeq™ 1000 and 2000 product updates and features of the on-board DRAGEN Bio-IT platform. We will cover the basics of how the flexibility and streamlined ...
Now Commercially Available, Both NextSeq 1000 and NextSeq 2000 Sequencers Include Integrated Informatics and Loss-less Compression Technology, Creating an Intuitive User Experience Now commercially ...
SAN DIEGO--(BUSINESS WIRE)-- Illumina, Inc. (NASDAQ: ILMN) further demonstrated its commitment to making genomics more accessible for the potential benefit of patients today with a series of ...
Illumina CEO Francis deSouza on Monday unveiled two new sequencing systems, NextSeq 2000 (pictured) and NextSeq 1000, both designed to meet growing demand for clinical genomic data at reduced cost, as ...
Next-generation sequencing (NGS) is a powerful tool, and it’s use is growing in basic research and clinical laboratories. Illumina continues to raise the bar on genomic sequencing, democratizing NGS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results